Christopher M. Smith - Feb 23, 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Executive Officer
Signature: /s/ Ali Olivo, Attorney-in-Fact
Stock symbol: NEO
Transactions as of: Feb 23, 2025
Transactions value $: $0
Form type: 4
Date filed: 2/25/2025, 04:37 PM
Previous filing: Feb 3, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Options Exercise	$0	+57.4K	+9.6%	$0.00	656K	Feb 23, 2025	Direct	F1
transaction	NEO	Common Stock	Tax liability	$0	-14.1K	-2.15%	$0.00	642K	Feb 23, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Restricted Stock Unit	Options Exercise	$0	-57.4K	-33.33%	$0.00	115K	Feb 23, 2025	Common Stock	57.4K	$0.00	Direct	F3, F4
holding	NEO	Stock Option (Right to Buy)						694K	Feb 23, 2025	Common Stock	694K	$12.62	Direct	F5
holding	NEO	Stock Option (Right to Buy)						270K	Feb 23, 2025	Common Stock	270K	$19.65	Direct	F6
holding	NEO	Restricted Stock Unit						96.1K	Feb 23, 2025	Common Stock	96.1K	$0.00	Direct	F4, F7
holding	NEO	Performance Stock Unit						144K	Feb 23, 2025	Common Stock	144K	$0.00	Direct	F4, F8
holding	NEO	Stock Option (Right to Buy)						288K	Feb 23, 2025	Common Stock	288K	$16.45	Direct	F9
holding	NEO	Performance Stock Unit						172K	Feb 23, 2025	Common Stock	172K	$0.00	Direct	F4, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
F2	Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
F3	On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F4	Once vested, the shares of common stock are not subject to expiration.
F5	On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F6	On May 11, 2023, Mr. Smith was granted 269,841 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F7	On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F8	On May 11, 2023, Mr. Smith was granted 144,190 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 216,285. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F9	On February 23, 2024, Mr. Smith was granted 287,940 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F10	On February 23, 2024, Mr. Smith was granted 172,240 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 258,360. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.